Tag Archives: CHD
March 2016 Br J Cardiol 2016;23:10–11
In brief
BJCardio Staff
Approval for new heart failure treatment A breakthrough drug for the treatment of chronic heart failure is now available in the UK. The new drug sacubitril/valsartan (Entresto®, Novartis) has been approved for the treatment of adults with symptomatic heart failure with reduced left ventricular ejection fraction (HFREF). Sacubitril/valsartan – the first drug in the angiotensin receptor neprilysin inhibitor (ARNI) class of drugs – was found to be superior to an evidence-based dose of the angiotensin-converting enzyme (ACE) inhibitor, enalapril, in the PARADIGM-HF study, the largest heart failure study conducted to date. PARADIGM-HF (Pros
March 2009 Br J Cardiol 2009;16:80-84
10 steps before you refer for chest pain
Sudhakar Allamsetty, Sreekala Seepana, Kathryn E Griffith
1. Take a detailed history Table 1. Clinical classification of chest pain (more…)
January 2006 Br J Cardiol 2006;13:36-41
Meeting the NSF targets for door-to-needle time in acute myocardial infarction – the role of a bolus thrombolytic
Velmurugan C Kuppuswamy, Daniela Webbe, Sandeep Gupta
No content available
March 2003 Br J Cardiol 2003;10:101-4
Better care without delay: acute myocardial infarction
BJCardio editorial team
No content available
For healthcare professionals only
